Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Nectar Lifesciences stock

NECLIFE.NS
INE023H01027

Price

38.89
Today +/-
-0.01
Today %
-2.44 %
P

Nectar Lifesciences stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Nectar Lifesciences stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Nectar Lifesciences stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Nectar Lifesciences stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Nectar Lifesciences's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Nectar Lifesciences Stock Price History

DateNectar Lifesciences Price
11/5/202438.89 undefined
11/4/202439.85 undefined
11/1/202439.00 undefined
10/31/202437.70 undefined
10/30/202435.93 undefined
10/29/202434.20 undefined
10/28/202433.27 undefined
10/25/202433.27 undefined
10/24/202434.87 undefined
10/23/202434.50 undefined
10/22/202434.76 undefined
10/21/202436.57 undefined
10/18/202437.28 undefined
10/17/202437.25 undefined
10/16/202437.01 undefined
10/15/202437.51 undefined
10/14/202438.00 undefined
10/11/202439.10 undefined
10/10/202439.00 undefined
10/9/202439.50 undefined
10/8/202439.91 undefined

Nectar Lifesciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Nectar Lifesciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Nectar Lifesciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Nectar Lifesciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Nectar Lifesciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Nectar Lifesciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Nectar Lifesciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Nectar Lifesciences’s growth potential.

Nectar Lifesciences Revenue, EBIT and net profit per share

DateNectar Lifesciences RevenueNectar Lifesciences EBITNectar Lifesciences Net Income
202416.84 B undefined923.56 M undefined49.95 M undefined
202315.24 B undefined-51.98 M undefined-241.83 M undefined
202216.69 B undefined1.02 B undefined250 M undefined
202115.44 B undefined500 M undefined-733 M undefined
202023.66 B undefined1.59 B undefined318 M undefined
201927.83 B undefined2.01 B undefined476 M undefined
201819.01 B undefined1.72 B undefined523 M undefined
201717.44 B undefined1.62 B undefined553 M undefined
201617.93 B undefined1.82 B undefined542 M undefined
201516.44 B undefined1.9 B undefined663 M undefined
201416.38 B undefined2.05 B undefined621 M undefined
201316.26 B undefined2.14 B undefined857 M undefined
201213.13 B undefined1.95 B undefined732 M undefined
201110.62 B undefined1.95 B undefined1.04 B undefined
20108.46 B undefined1.67 B undefined916 M undefined
20097.28 B undefined1.23 B undefined528 M undefined
20087.36 B undefined1.16 B undefined744 M undefined
20074.33 B undefined744 M undefined467 M undefined
20062.6 B undefined557 M undefined380 M undefined
20052.3 B undefined397 M undefined219 M undefined

Nectar Lifesciences Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200020012003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
1.121.251.672.132.32.64.337.367.288.4610.6213.1316.2616.3816.4417.9317.4419.0127.8323.6615.4416.6915.2416.84
-11.4533.7928.017.6912.9766.9169.84-1.0716.1825.5723.6323.850.740.329.07-2.718.9846.42-14.97-34.748.05-8.7010.53
10.7316.7716.9218.7026.3330.6225.1323.6228.6331.5127.7124.6724.0124.0424.1821.5321.7019.2114.8115.5816.7417.9413.5318.76
0.120.210.280.40.610.81.091.742.082.672.943.243.93.943.983.863.783.654.123.692.592.992.063.16
0.060.130.170.240.40.560.741.161.231.671.951.952.142.051.91.821.621.722.011.590.51.02-0.050.92
5.4610.1910.1411.3917.2821.4617.1715.7516.9119.7018.3914.8413.1812.4911.5810.129.309.047.236.723.246.09-0.335.48
0.050.080.090.140.220.380.470.740.530.921.040.730.860.620.660.540.550.520.480.32-0.730.25-0.240.05
-67.3919.4853.2655.3273.5222.8959.31-29.0373.4813.76-29.7517.08-27.546.76-18.252.03-5.42-8.99-33.19-330.50-134.11-196.40-120.33
9191110110135138204208209217224224224224224224224224224224224224224.26224.26
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Nectar Lifesciences Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Nectar Lifesciences is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (B)OTHER REC. (B)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (B)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (B)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (B)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (B)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (M)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
200020012003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                               
3742699911626236035671073782606510332335113285202197243162178.67202.84
0.180.160.280.40.590.891.151.61.672.233.113.053.733.984.474.9156.125.593.963.754.473.244.09
0.060.10.080.120.170.681.211.410.951.021.050.950.690.350.430.651.131.021.81.771.641.210.73
0.170.280.40.470.811.211.9623.53.964.715.916.767.588.498.899.119.189.7310.086.557.217.327.77
00000002366105182212270216362731001441107066368.2548.04
0.450.580.821.091.693.044.695.276.847.779.4410.511.5112.3713.6914.6414.9616.6116.6916.1512.3913.5512.3112.84
0.280.290.450.60.831.433.064.2166.838.1910.0810.5210.799.379.269.068.858.618.327.656.96.56
01100100173102111111233332222.352.35
00000000000.50.630.710.870.80.871.011.11.111.180.150.120.070.1
00000000000000798680574459392392384430493.29523.93
000000000000000000000000
000.010.010.010.010.010.010000000000.010.010.012.642.152.111.89
0.280.30.460.610.841.543.084.226.017.048.6910.7111.2311.5710.6110.9210.8510.6310.3610.1811.4910.369.589.07
0.730.881.281.72.544.577.779.4912.8614.8118.1321.2122.7423.9424.325.5625.8127.2427.0526.3323.8823.9121.8921.91
                                               
142206110110110149149152152224224224224224224224224224224224224224224.26224.26
00000.10.920.740.720.492.722.723.293.293.293.293.293.293.293.293.293.293.293.293.29
0.070.150.320.420.520.891.311.992.43.284.264.335.165.765.516.036.567.077.547.857.117.377.097.18
0000339-18-8-1800000000000043.030
000000000000000000000000
0.210.350.430.530.731.962.212.843.036.217.217.848.689.279.029.5410.0710.5911.0511.3610.6210.8810.6510.69
0.160.140.250.350.460.410.551.071.751.351.41.953.834.44.594.975.285.395.325.273.423.773.194.2
000000000022272530392812010298711138764.96113.7
1944145172253410566425624742991277415479342236242247208563588497383.21465.58
00000000004.775.655.095.85.956.276.36.346.366.27.125.034.594.12
00000000000.851.141.090.550.640.90.841.011.020.380.630.660.680.83
0.180.180.390.530.710.821.121.492.382.098.039.0410.4511.2611.5612.412.7913.091312.4811.8810.048.919.73
0.330.340.380.530.971.644.224.857.046.012.343.642.612.232.662.451.642.21.661.221.282.912.261.4
000.080.110.120.150.220.30.40.50.510.630.961.120.840.931.041.081.121.170000
0000000000355448572222432822752221131058072.1786.82
0.330.340.460.641.091.794.445.157.456.512.894.323.623.413.713.622.963.5632.491.392.992.341.49
0.510.520.851.171.82.615.566.659.828.610.9113.3614.0714.6715.2816.0215.7416.651614.9713.2613.0311.2511.22
0.730.881.281.72.544.577.779.4912.8614.818.1221.2122.7423.9424.325.5625.8127.2427.0526.3323.8823.9121.8921.91
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Nectar Lifesciences provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Nectar Lifesciences's financial health and stability.

Assets

Nectar Lifesciences's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Nectar Lifesciences must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Nectar Lifesciences after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Nectar Lifesciences's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (B)PAID INTEREST (B)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (B)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.110.180.280.460.530.830.641.151.20.851.150.780.850.650.670.630.590.37-0.590.34-0.42
40506683115194303387461607759841765573622643632607602569591
000000000000000000000
-67-179-303-1,020-765242-97-1,440-1,987-773664-362-1,255-700-275-1,733-267610-442-645779
0.050.080.090.140.160.230.470.450.760.961.041.291.091.170.971.121.441.260.650.690.39
0.060.070.080.10.210.270.50.60.741.031.151.381.261.231.171.151.481.261.120.790.79
122140443111310312612612918199628571126135933700
0.140.120.13-0.340.041.491.320.550.441.653.612.551.441.691.990.652.392.850.210.951.34
-117-202-297-682-1,741-1,344-1,847-1,419-1,999-2,589-1,206-1,015-805-823-533-331-381-547-312-249-300
-112-201-302-673-1,684-1,197-1,815-1,455-1,686-2,335-989-899-595-768-181-294-261-331-286166517
50-585714631-36313254216115209543523712021626416817
000000000000000000000
-0.020.120.20.331.93-0.320.89-0.51.971.67-1.64-0.210.660.37-0.840.77-0.52-1.251.25-0.4-1.06
0000.040002.520000000000000
-0.020.110.191.161.74-0.390.580.911.230.62-2.82-1.61-0.61-0.89-2.04-0.4-2.01-2.520.11-1.19-1.86
0-10-11823-186-48-246-1,061-740-1,031-1,156-1,375-1,255-1,233-1,174-1,152-1,481-1,258-1,120-788-794
000-250-29-60-530-22-22-22-22-27-27-13-13-13-11-100
6291714697-99843-22-66-1963723432-234-38120042-77-2
17.1-77.8-167.8-1,026.6-1,701.2148.2-530.1-865.9-1,561.7-939.92,402.31,532.9639.1864.61,453.8320.12,011.12,301.9-98.6700.41,035.91
000000000000000000000

Nectar Lifesciences stock margins

The Nectar Lifesciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Nectar Lifesciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Nectar Lifesciences.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Nectar Lifesciences's sales revenue. A higher gross margin percentage indicates that the Nectar Lifesciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Nectar Lifesciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Nectar Lifesciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Nectar Lifesciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Nectar Lifesciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Nectar Lifesciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Nectar Lifesciences Margin History

Nectar Lifesciences Gross marginNectar Lifesciences Profit marginNectar Lifesciences EBIT marginNectar Lifesciences Profit margin
202418.76 %5.48 %0.3 %
202313.54 %-0.34 %-1.59 %
202217.94 %6.09 %1.5 %
202116.74 %3.24 %-4.75 %
202015.58 %6.72 %1.34 %
201914.81 %7.23 %1.71 %
201819.21 %9.04 %2.75 %
201721.7 %9.3 %3.17 %
201621.53 %10.12 %3.02 %
201524.18 %11.58 %4.03 %
201424.04 %12.49 %3.79 %
201324.01 %13.18 %5.27 %
201224.67 %14.84 %5.57 %
201127.71 %18.39 %9.81 %
201031.51 %19.7 %10.83 %
200928.63 %16.91 %7.25 %
200823.62 %15.75 %10.11 %
200725.13 %17.17 %10.78 %
200630.62 %21.46 %14.64 %
200526.33 %17.28 %9.53 %

Nectar Lifesciences Stock Sales Revenue, EBIT, Earnings per Share

The Nectar Lifesciences earnings per share therefore indicates how much revenue Nectar Lifesciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Nectar Lifesciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Nectar Lifesciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Nectar Lifesciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Nectar Lifesciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Nectar Lifesciences Revenue, EBIT and net profit per share

DateNectar Lifesciences Sales per ShareNectar Lifesciences EBIT per shareNectar Lifesciences Earnings per Share
202475.09 undefined4.12 undefined0.22 undefined
202367.94 undefined-0.23 undefined-1.08 undefined
202274.5 undefined4.54 undefined1.12 undefined
202168.95 undefined2.23 undefined-3.27 undefined
2020105.64 undefined7.1 undefined1.42 undefined
2019124.24 undefined8.98 undefined2.13 undefined
201884.85 undefined7.67 undefined2.33 undefined
201777.86 undefined7.24 undefined2.47 undefined
201680.03 undefined8.1 undefined2.42 undefined
201573.38 undefined8.5 undefined2.96 undefined
201473.14 undefined9.13 undefined2.77 undefined
201372.6 undefined9.57 undefined3.83 undefined
201258.62 undefined8.7 undefined3.27 undefined
201147.42 undefined8.72 undefined4.65 undefined
201038.98 undefined7.68 undefined4.22 undefined
200934.83 undefined5.89 undefined2.53 undefined
200835.38 undefined5.57 undefined3.58 undefined
200721.24 undefined3.65 undefined2.29 undefined
200618.81 undefined4.04 undefined2.75 undefined
200517.02 undefined2.94 undefined1.62 undefined

Nectar Lifesciences business model

Nectar Lifesciences is one of the most popular companies on Eulerpool.com.

Nectar Lifesciences Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Nectar Lifesciences historical P/E ratio, EBIT multiple, and P/S ratio

Nectar Lifesciences shares outstanding

The number of shares was Nectar Lifesciences in 2023 — This indicates how many shares 224.261 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Nectar Lifesciences earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Nectar Lifesciences's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Nectar Lifesciences’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Nectar Lifesciences's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Nectar Lifesciences stock splits

In Nectar Lifesciences's history, there have been no stock splits.

Nectar Lifesciences dividend history and estimates

In 2023, Nectar Lifesciences paid a dividend amounting to 0 INR. Dividend means that Nectar Lifesciences distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Nectar Lifesciences provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Nectar Lifesciences’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Nectar Lifesciences's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Nectar Lifesciences Dividend History

DateNectar Lifesciences Dividend
20200.05 undefined
20190.05 undefined
20180.05 undefined
20170.05 undefined
20160.1 undefined
20150.1 undefined
20140.1 undefined
20130.1 undefined
20120.1 undefined
20110.1 undefined
20100.25 undefined
20090.1 undefined
20080.4 undefined

Nectar Lifesciences dividend payout ratio

In 2023, Nectar Lifesciences had a payout ratio of 3.02%. The payout ratio indicates the percentage of the company's profits that Nectar Lifesciences distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Nectar Lifesciences represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Nectar Lifesciences could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Nectar Lifesciences's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Nectar Lifesciences Payout Ratio History

DateNectar Lifesciences Payout ratio
20242.85 %
20233.02 %
20222.85 %
20212.68 %
20203.52 %
20192.36 %
20182.15 %
20172.02 %
20164.13 %
20153.39 %
20143.61 %
20132.62 %
20123.07 %
20112.15 %
20105.91 %
20093.95 %
200811.2 %
20072.68 %
20062.68 %
20052.68 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Nectar Lifesciences.

Nectar Lifesciences latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20150.82 0.77  (-5.64 %)2016 Q2
9/30/20140.95 0.73  (-23.04 %)2015 Q2
1

Nectar Lifesciences shareholders

%
Name
Stocks
Change
Date
24.90206 % Goyal (Sanjiv)55,845,60009/30/2024
19.45162 % Sanjiv HUF43,622,40009/30/2024
1.06439 % Citco Bank2,387,01209/30/2024
0.04367 % Investor Education Protection Fund97,92909/30/2024
0.01434 % Acadian Asset Management LLC32,16109/30/2024
0.00099 % Avantis Investors2,21406/30/2024
0 % NSR Direct PE Mauritius, L.L.C.0-25,890,9659/23/2024
0 % Motilal Oswal Asset Management Company Ltd.0-6869/30/2023
1

Nectar Lifesciences Executives and Management Board

Mr. Sanjiv Goyal
Nectar Lifesciences Executive Chairman of the Board, Managing Director
Compensation 19.86 M
Dr. Rupinder Tewari
Nectar Lifesciences Independent Non-Executive Director
Compensation 114,000
Mr. Ajay Swaroop
Nectar Lifesciences Independent Non-Executive Director
Compensation 107,000
Dr. Kuldip Bhasin
Nectar Lifesciences Independent Non-Executive Director
Compensation 80,000
Mr. Amit Chadah
Nectar Lifesciences Chief Executive Officer
1
2

Most common questions regarding Nectar Lifesciences

What is the P/E ratio of Nectar Lifesciences 2024?

The Nectar Lifesciences P/E ratio is 174.6.

What is the P/S ratio of Nectar Lifesciences 2024?

The Nectar Lifesciences P/S ratio is 0.52.

What is the Quality Investing of Nectar Lifesciences?

The Quality Investing for Nectar Lifesciences is 2/10.

What is the revenue of Nectar Lifesciences 2024?

The Nectar Lifesciences revenue is 16.84 B INR.

How high is the profit of Nectar Lifesciences 2024?

The Nectar Lifesciences profit is 49.95 M INR.

What is the business model of Nectar Lifesciences

No history available for Nectar Lifesciences.

What is the Nectar Lifesciences dividend?

Nectar Lifesciences pays a dividend of 0 INR distributed over payouts per year.

How often does Nectar Lifesciences pay dividends?

The dividend cannot currently be calculated for Nectar Lifesciences or the company does not pay out a dividend.

What is the Nectar Lifesciences ISIN?

The ISIN of Nectar Lifesciences is INE023H01027.

What is the Nectar Lifesciences ticker?

The ticker of Nectar Lifesciences is NECLIFE.NS.

How much dividend does Nectar Lifesciences pay?

Over the past 12 months, Nectar Lifesciences paid a dividend of 0.05 INR . This corresponds to a dividend yield of about 0.13 %. For the coming 12 months, Nectar Lifesciences is expected to pay a dividend of 0 INR.

What is the dividend yield of Nectar Lifesciences?

The current dividend yield of Nectar Lifesciences is 0.13 %.

When does Nectar Lifesciences pay dividends?

Nectar Lifesciences pays a quarterly dividend. This is distributed in the months of October, October, October, October.

How secure is the dividend of Nectar Lifesciences?

Nectar Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Nectar Lifesciences?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nectar Lifesciences located?

Nectar Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nectar Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nectar Lifesciences from 10/20/2020 amounting to 0.05 INR, you needed to have the stock in your portfolio before the ex-date on 9/11/2020.

When did Nectar Lifesciences pay the last dividend?

The last dividend was paid out on 10/20/2020.

What was the dividend of Nectar Lifesciences in the year 2023?

In the year 2023, Nectar Lifesciences distributed 0 INR as dividends.

In which currency does Nectar Lifesciences pay out the dividend?

The dividends of Nectar Lifesciences are distributed in INR.

All fundamentals about Nectar Lifesciences

Our stock analysis for Nectar Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nectar Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.